Overview A Study for Type 2 Diabetic Patients Status: Completed Trial end date: 2009-08-01 Target enrollment: Participant gender: Summary The purpose of the study is to compare the insulin lispro low mixture (1, 2 or 3 daily injections) with insulin glargine (alone or with 1, 2 or 3 insulin lispro daily injections) on lowering the blood sugar level Phase: Phase 4 Details Lead Sponsor: Eli Lilly and CompanyTreatments: InsulinInsulin GlargineInsulin LisproInsulin, Globin Zinc